Diabetic Polyneuropathy Not Up With Impaired Glycemia Although significantly increased in subjects with new diabetes, the rates of typical diabetic polyneuropathy (DPN), retinopathy, and nephropathy ...

Please provide your email address to receive an email when new articles are posted on . Diabetic peripheral neuropathy is associated with a decline in cognition for people with type 2 diabetes, ...

Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among adults with type 2 diabetes, those ...

Neurologists can play an important role in addressing the alarming increase in diabetic peripheral neuropathy (DPN), a troubling result of the obesity and type 2 diabetes pandemics. Eva L. Feldman, MD ...

A new scale to help clinicians assess the health-related quality of life of patients with diabetic distal sensorimotor polyneuropathy (DSPN) has been validated in clinical settings, researchers ...

Lower vitamin D (25-hydroxyvitamin D) levels are found in patients with painful diabetic peripheral neuropathy (DPN) compared to those with painless DPN, patients with diabetes without any neuropathy, ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

However, prevalence was found to plateau over time, suggesting neuropathic pain may be isolated or intermittent events in some patients with type 1 diabetes. “The features and burden of neuropathic ...

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...

Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities ...

Looking at data on 3,496 adults with newly diagnosed diabetic peripheral neuropathy, the percentage of patients who received a new prescription for pain medication dropped from 46% in 2014 to 35% in ...